1,095
Views
13
CrossRef citations to date
0
Altmetric
Clinical focus: Multimodal Analgesia - Review

Neuropharmacological basis for multimodal analgesia in chronic pain

ORCID Icon & ORCID Icon
Pages 245-259 | Received 11 Mar 2021, Accepted 22 Sep 2021, Published online: 28 Oct 2021
 

ABSTRACT

Managing chronic pain remains a major unmet clinical challenge. Patients can be treated with a range of interventions, but pharmacotherapy is the most common. These include opioids, antidepressants, calcium channel modulators, sodium channel blockers, and nonsteroidal anti-inflammatory drugs. Many of these drugs target a particular mechanism; however, chronic pain in many diseases is multifactorial and induces plasticity throughout the sensory neuroaxis. Furthermore, comorbidities such as depression, anxiety, and sleep disturbances worsen quality of life. Given the complexity of mechanisms and symptoms in patients, it is unsurprising that many fail to achieve adequate pain relief from a single agent. The efforts to develop novel drug classes with better efficacy have not always proved successful; a multimodal or combination approach to analgesia is an important strategy in pain control. Many patients frequently take more than one medication, but high-quality evidence to support various combinations is often sparse. Ideally, combining drugs would produce synergistic action to maximize analgesia and reduce side effects, although sub-additive and additive analgesia is still advantageous if additive side-effects can be avoided. In this review, we discuss pain mechanisms, drug actions, and the rationale for mechanism-led treatment selection.

Abbreviations: COX – cyclooxygenase, CGRP – calcitonin gene-related peptide, CPM – conditioned pain modulation, NGF – nerve growth factor, NNT – number needed to treat, NMDA – N-methyl-d-aspartate, NSAID – nonsteroidal anti-inflammatory drugs, TCA – tricyclic antidepressant, SNRI – serotonin-noradrenaline reuptake inhibitor, QST – quantitative sensory testing.

Acknowledgments

None stated.

Transparency

Declaration of financial/other relationships

No potential conflict of interest was reported by the author.

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper is not funded.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 708.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.